NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.20
+0.35 (2.95%)
Mar 31, 2025, 2:35 PM EDT - Market open

NeuroPace Statistics

Total Valuation

NeuroPace has a market cap or net worth of $397.23 million. The enterprise value is $406.42 million.

Market Cap 397.23M
Enterprise Value 406.42M

Important Dates

The last earnings date was Tuesday, March 4, 2025, after market close.

Earnings Date Mar 4, 2025
Ex-Dividend Date n/a

Share Statistics

NeuroPace has 32.56 million shares outstanding. The number of shares has increased by 12.67% in one year.

Current Share Class 32.56M
Shares Outstanding 32.56M
Shares Change (YoY) +12.67%
Shares Change (QoQ) +1.60%
Owned by Insiders (%) 3.57%
Owned by Institutions (%) 30.33%
Float 21.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.32
Forward PS 4.03
PB Ratio 44.58
P/TBV Ratio 48.15
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.09
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.37, with a Debt / Equity ratio of 9.15.

Current Ratio 5.37
Quick Ratio 4.33
Debt / Equity 9.15
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.46

Financial Efficiency

Return on equity (ROE) is -189.35% and return on invested capital (ROIC) is -15.53%.

Return on Equity (ROE) -189.35%
Return on Assets (ROA) -13.39%
Return on Invested Capital (ROIC) -15.53%
Return on Capital Employed (ROCE) -27.26%
Revenue Per Employee $434,272
Profits Per Employee -$147,505
Employee Count 184
Asset Turnover 0.79
Inventory Turnover 1.69

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.17% in the last 52 weeks. The beta is 2.07, so NeuroPace's price volatility has been higher than the market average.

Beta (5Y) 2.07
52-Week Price Change -9.17%
50-Day Moving Average 12.63
200-Day Moving Average 9.28
Relative Strength Index (RSI) 50.10
Average Volume (20 Days) 216,197

Short Selling Information

The latest short interest is 308,344, so 0.95% of the outstanding shares have been sold short.

Short Interest 308,344
Short Previous Month 245,600
Short % of Shares Out 0.95%
Short % of Float 1.46%
Short Ratio (days to cover) 0.87

Income Statement

In the last 12 months, NeuroPace had revenue of $79.91 million and -$27.14 million in losses. Loss per share was -$0.93.

Revenue 79.91M
Gross Profit 59.09M
Operating Income -21.67M
Pretax Income -31.51M
Net Income -27.14M
EBITDA -21.46M
EBIT -21.67M
Loss Per Share -$0.93
Full Income Statement

Balance Sheet

The company has $52.76 million in cash and $73.34 million in debt, giving a net cash position of -$20.58 million or -$0.63 per share.

Cash & Cash Equivalents 52.76M
Total Debt 73.34M
Net Cash -20.58M
Net Cash Per Share -$0.63
Equity (Book Value) 8.01M
Book Value Per Share 0.27
Working Capital 66.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.95 million and capital expenditures -$306,000, giving a free cash flow of -$18.26 million.

Operating Cash Flow -17.95M
Capital Expenditures -306,000
Free Cash Flow -18.26M
FCF Per Share -$0.56
Full Cash Flow Statement

Margins

Gross margin is 73.94%, with operating and profit margins of -27.12% and -33.97%.

Gross Margin 73.94%
Operating Margin -27.12%
Pretax Margin -33.97%
Profit Margin -33.97%
EBITDA Margin -26.86%
EBIT Margin -27.12%
FCF Margin n/a

Dividends & Yields

NeuroPace does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.67%
Shareholder Yield n/a
Earnings Yield -7.03%
FCF Yield -4.73%

Analyst Forecast

The average price target for NeuroPace is $14.83, which is 21.56% higher than the current price. The consensus rating is "Buy".

Price Target $14.83
Price Target Difference 21.56%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 25.28%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NeuroPace has an Altman Z-Score of -4.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.96
Piotroski F-Score 3